# Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

> **NCT01654120** · PHASE4 · COMPLETED · sponsor: **Mountain Diabetes and Endocrine Center** · enrollment: 37 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT01654120
- **Lead sponsor:** Mountain Diabetes and Endocrine Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654120, "Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01654120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*